Various preparations of Bald’s eyesalve were analysed by reversed-phase HPLC on an Agilent 1,200 series system fitted with an Agilent ZORBAX Eclipse XDB-C18, 150 × 4.6 mm, 5 μm particle size column and diode array detection at 210 nm. A gradient of methanol (5–95%) in water was used at a flow rate of 1 ml·min−1 over 30 min. Injection volume was 10 μl, and the column temperature was 25 °C.
To identify the concentration of allicin in eyesalve preparations, a calibration curve was prepared by serially diluting an external allicin standard (Abcam, Cambridge) in water (twofold dilutions, from 750 μg·ml−1 to 0.5 μg·ml−1). External standards were run through HPLC as described above (n = 2) and allicin peak area, in the 210 nm reading, was plotted against concentration (μg·ml−1) (Fig.